Strategic Partnerships Sequenex recently announced a partnership with MedTech Innovator, a leading startup accelerator. This presents a direct avenue to engage portfolio companies and graduates that need medical device software development, regulatory-compliant platforms, and accelerate go-to-market timelines.

NEX Platform Value The launch of NEX, a customizable software platform for biosensor-integrated and BLE-connected devices, signals a repeatable, scalable offering that can shorten development cycles for SaMD and CGM projects. Target medtech companies seeking rapid MVP to Clinical to Commercial progression.

Regulatory Edge All work is performed under an ISO 13485 certified QMS, emphasizing traceability and regulatory readiness. This can be a compelling differentiator for manufacturers needing compliant software foundations, reducing risk and audit burden.

Market Focus Fit Customer profile includes connected medical devices and biosensors with regulatory needs and device-agnostic integration. Sales opportunities exist with medtech firms looking to modernize software stacks while maintaining compliance and scalability.

Growth Signals Revenue in the low-to-mid single digits with a lean team (11-50 employees) suggests agility and cost-effective engagement for bespoke software or staff augmentation. Potential for scalable projects with accelerated timelines and clear ROI.